UroGen Pharma (URGN) Inventory Average (2018 - 2026)
UroGen Pharma's (URGN) quarterly Inventory Average came in at $18.7 million in Q1 2026, up 122.3% YoY from $8.4 million in Q1 2025, and up 50.72% on a QoQ basis from $12.4 million in Q4 2025.
UroGen Pharma (URGN) Inventory Average (2018 - 2026) Analysis & Trends
UroGen Pharma (URGN) has 8 years of Inventory Average data on file, last reported at $18.7 million in Q1 2026.
- Quarterly Inventory Average rose 122.3% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 122.3% YoY) and the FY2025 annual result came in at $12.8 million, up 72.42% from the prior year.
- Inventory Average rose to $18.7 million in Q1 2026, from $12.4 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $18.7 million in Q1 2026 to a low of $4.6 million in Q4 2022.
- A 5-year average of $7.3 million and a median of $6.5 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2025 — Inventory Average gained 0.22% — and 2026, when it surged 122.3%.
- Tracing URGN's Inventory Average over 5 years: stood at $4.6 million in 2022, then climbed by 16.2% to $5.3 million in 2023, then surged by 57.57% to $8.4 million in 2024, then soared by 47.46% to $12.4 million in 2025, then jumped by 50.72% to $18.7 million in 2026.
- The last three Inventory Average figures came in at $18.7 million (Q1 2026), $12.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | UroGen Pharma | 2.36 Bn | 2.25 Bn | 65.88 Mn | 22.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.76 Mn |
| Mar 31, 2026 | 18.69 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | 7.73 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Mar 31, 2025 | 8.41 Mn |
| Dec 31, 2024 | 8.41 Mn |
| Sep 30, 2024 | 7.52 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Dec 31, 2023 | 5.34 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 4.79 Mn |
| Dec 31, 2021 | 4.32 Mn |
| Sep 30, 2021 | 3.61 Mn |